PLACE OF CEFIXIME IN THE TREATMENT OF URINARY TRACT INFECTIONS
- Authors: Fomin V.V.1, Fomin VV1
-
Affiliations:
- Issue: No 15 (2011)
- Pages: 69-72
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278988
- ID: 278988
Cite item
Full Text
Abstract
The article considers the reasons for urinary tract infections (UTI); the principles of rational antibacterial therapy are discussed. It is noted that among the antibacterial agents used for treatment of UTI, III generation cephalosporins, particularly cefixime, have attracted particular attention in terms of efficiency and good tolerability. The results of clinical studies of cefixime are presented. It is emphasized that cefixime can be considered as first-line treatment for most variants of UTI, including acute cystitis and acute pyelonephritis. Particularly, its use is justified in the presence of β-lactamase-producing pathogens. Cefixime can be considered as a treatment of choice in poor tolerance of other treatment options, as well as in groups of patients with highest risk of adverse events (children, elderly patients, pregnant women).
References
- Eriksson I, Gustafson Y, Fagerström L, Olofsson B. Prevalence and factors associated with urinary tract infections (UTIs) in very old women. Arch Gerontol Geriatr 2010;50(2):132-35.
- Bjerklund Johansen TE, Cek M, Naber K, et al. Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 2007;51(4):1100-11.
- Wazait HD, Patel HR, Veer V, et al. Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996-2001). BJU Int 2003;91(9):806-09.
- Kurtaran B, Candevir A, Tasova Y, et al. Antibiotic resistance in community-acquired urinary tract infections: prevalence and risk factors. Med Sci Monit 2010;16(5):CR246-CR251.
- Рафальский В.В., Дивгань Е.В., Деревицкий А.В. Цефексим: клиническая фармакология и роль в терапии урогенитальных инфекций // Урология 2011. № 2. С. 63-6.
- Wu DH. A review of the safety profile of cefixime. Clin Ther 1993;15(6):1108-19.
- Айламазян Э.Т. Применение цефиксима при неосложненном пиелонефрите беременных (методические рекомендации для акушеров-гинекологов) // Consilium Medicum. Гинекология 2006. № 8 (3). С. 14-19.
- Kameoka H, Takano Y, Miyoshi S, et al. Clinical experience with cefixime in urinary tract infections. Jap J Antib 1989;42:2540-47.
- García-Rodríguez JA. Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results. Chemotherapy 1998;44(1):28-30.
- Levenstein J, Summerfield PJ, Fourie S, et al. Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study. S Afr Med J 1986;70(8):455-60.
- Dagan R, Einhorn M, Lang R, et al. Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children. Pediatr Infect Dis J 1992;11(3):198-203.
- Asbach HW. Single dose oral administration of cefixime 400 mg in the treatment of acute uncomplicated cystitis and gonorrhoea. Drugs 1991;42:10-3.
- Iravani A, Richard G, Johnson D, Bryant A. A double-blinding, multicenter comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patient. Am J Med 1988;85:17-25.
- Seko S, Sumii T, Nakano H, et al. Clinical studies of cefixime in the urological field. Chemotherapy 1985;33:735-50.
- Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999;104:79-86.
Supplementary files
